PROFUND ADVISORS LLC

Position in ROIV — Roivant Sciences Ltd.

CIK 1129919 BETHESDA, MD

Position in ROIV

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$2,008,417

-$109,164 QoQ

Shares Held

56,751

-25.8% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#196

of 494 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PROFUND ADVISORS LLC holds $162,985,629 across 169 Biotechnology names. ROIV ranks #11 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	23,398	$11,622,488
2	REGN	Regeneron Pharmaceuticals, Inc.	10,444	$6,512,251
3	ALNY	Alnylam Pharmaceuticals, Inc.	13,814	$4,158,428
4	MRNA	Moderna, Inc.	33,142	$2,320,934
5	APGE	Apogee Therapeutics, Inc.	17,163	$2,278,044
6	CYTK	Cytokinetics Inc	25,572	$2,178,478
7	KRYS	Krystal Biotech, Inc.	5,770	$2,144,535
8	KYMR	Kymera Therapeutics, Inc.	18,455	$2,116,234

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,008,417	56,751	-25.8%	Shares	Sole	2026-08-11
2026-03-31	$2,117,581	76,447	-32.4%	Shares	Sole	2026-04-27
2025-12-31	$2,452,816	113,033	+6.0%	Shares	Sole	2026-02-06
2025-09-30	$1,613,448	106,639	-16.4%	Shares	Sole	2025-11-06
2025-06-30	$1,437,387	127,541	+17.6%	Shares	Sole	2025-08-07
2025-03-31	$1,093,937	108,418	-23.3%	Shares	Sole	2025-05-08
2024-12-31	$1,673,140	141,432	+3.9%	Shares	Sole	2025-02-14
2024-09-30	$1,571,297	136,161	-13.1%	Shares	Sole	2024-11-14
2024-06-30	$1,656,572	156,724	+10.1%	Shares	Sole	2024-08-13
2024-03-31	$1,500,337	142,347	-1.2%	Shares	Sole	2024-05-08
2023-12-31	$1,618,411	144,115	+24.2%	Shares	Sole	2024-02-14
2023-09-30	$1,354,985	116,009	-9.3%	Shares	Sole	2023-11-13
2023-06-30	$1,289,010	127,878	-5.7%	Shares	Sole	2023-08-10
2023-03-31	$1,000,587	135,581	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.